TR
Tessa Romero JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
18%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
60%
Neutral
20%
Negative
20%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $20 |
27%
downside
| 1 | – |
–
| 21 Nov ‘25 13 days ago |
|
|
|
Overweight
Maintained
| $15 |
58%
upside
| 1 | -30% |
0
%
| 20 Nov ‘25 14 days ago |
|
|
|
Overweight
Maintained
| $60 |
35%
upside
| 1 | +9% |
0
%
| 18 Nov ‘25 16 days ago |
|
|
|
Overweight
Maintained
| $47 |
4%
upside
| 1 | +23% |
0
%
| 18 Nov ‘25 16 days ago |
|
|
|
Underweight
Downgraded
| $263 |
7,545%
upside
| 1 | -13% |
0
%
| 18 Nov ‘25 16 days ago |
|
|
|
Overweight
Maintained
| $31 |
17%
upside
| 2 | +9% |
0
%
| 17 Nov ‘25 17 days ago |
|
|
|
Neutral
Maintained
| $17 |
19%
downside
| 1 | – |
–
| 14 Nov ‘25 20 days ago |
|
|
|
Overweight
Maintained
| $34 |
43%
upside
| 1 | +20% |
0
%
| 14 Nov ‘25 20 days ago |
|
|
|
Underweight
Downgraded
| – | – | 1 | -55% |
0
%
| 16 Sep ‘25 2 months ago |
|